Patent · US Active

Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines

US9550773B2 · kind B2 · utility

5Cited by
169References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 13, 2015
Grant dateJan 24, 2017
Priority date
Expiry dateApr 13, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.